Internal Medicine, Endocrinology, Diabetes, & Metabolism · Ponce, PR
NPI
1669498358
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
Dr Ulises Clavell 23
Ponce, PR, 00716
Phone (787) 259-4463
Medicare paid, 2024
$5,366
108 services
Medicare patients, 2024
76
Average age 75
Drug cost, 2024
$2.6M
17,331 prescriptions
Company payments, 2025
$1,527
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Francisco J Nadal Colon was code 99213 (office e&m - established), 72 times for 44 patients. In total Francisco J Nadal Colon billed 108 services in 3 codes, and Medicare paid $5,366.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 72 | 44 | $47.78 | $3,440 |
| 95922 Electrical Nerve Conductivity | Office | 32 | 32 | $54.16 | $1,733 |
By year: 2022 $6,241 for 129 services; 2023 $7,447 for 130 services; 2024 $5,366 for 108 services.
Medicare prescription drug claims, 2024
In 2024, the drug Francisco J Nadal Colon prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 2,127 prescriptions and refills. In total Francisco J Nadal Colon wrote 17,331 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 2,127 | 4,200 | 496 | $188K |
| Metformin Hcl Generic | 1,217 | 2,597 | 336 | $9,707 |
| Atorvastatin Calcium Generic | 949 | 2,111 | 315 | $11K |
| Glimepiride Generic | 872 | 1,873 | 238 | $14K |
| Simvastatin Generic | 834 | 1,817 | 260 | $7,650 |
| Levothyroxine Sodium Generic | 709 | 1,492 | 194 | $9,784 |
| Losartan Potassium Generic | 658 | 1,388 | 194 | $7,551 |
| Rosuvastatin Calcium Generic | 608 | 1,221 | 181 | $7,697 |
| Gabapentin Generic | 560 | 1,075 | 161 | $7,716 |
| Farxiga Dapagliflozin Propanediol | 484 | 854 | 134 | $493K |
| Jardiance Empagliflozin | 458 | 647 | 115 | $397K |
| Lantus Insulin Glargine,hum.Rec.Anlog | 375 | 529 | 92 | $48K |
| Fenofibrate Generic | 343 | 655 | 87 | $8,807 |
| Amlodipine Besylate Generic | 311 | 667 | 97 | $1,616 |
| Trulicity Dulaglutide | 289 | 294 | 48 | $290K |
Brand drugs: 6,312 claims; generic drugs: 10,613 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Francisco J Nadal Colon $1,527 ($1,527 in general payments such as food, travel and fees) from 10 companies. The largest payer was Amgen Inc. with $535.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 5 | $535 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $510 |
| Corcept Therapeutics CORT | 2 | $137 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $121 |
| Novo Nordisk Inc NVO | 1 | $56.48 |
| Radius Health, Inc. | 1 | $50.56 |
| Pfizer Inc. PFE | 2 | $38.93 |
| Bayer Puerto Rico Inc. BAYN.DE | 1 | $28.56 |
| Dexcom, Inc. DXCM | 1 | $24.19 |
| Abbott Laboratories ABT | 1 | $24.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.